Risk Factors for Rescue Therapy in Crohn’s Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up
Crossref DOI link: https://doi.org/10.1007/s10620-017-4771-z
Published Online: 2017-10-06
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fischer, Monika
Campbell, Sarah C.
Calley, Cynthia S. J.
Helper, Debra J.
Chiorean, Michael V.
Fadda, Hala M.
License valid from 2017-10-06